Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report.
We describe the use of a new urethral stent implanted into 12 patients with prostatic outflow obstruction. All were in a high risk group for surgery and 11 were treated successfully, with a follow-up of 1 to 11 months (median 9). The majority of patients were satisfied with the procedure, which provided a quick, safe and effective alternative to conventional surgical treatment. The stent, woven from fine stainless steel in the form of a tubular mesh, was inserted via a delivery device using combined ultrasound and endoscopic control under local anaesthesia. The procedure was well tolerated, the stent becoming covered with epithelium by 6 to 8 months following insertion, yet allowing easy removal within the first 4 to 6 weeks should the need arise. This technique provides a useful alternative to conventional surgical treatment in the high risk patient.
Department of Urology, Middlesex Hospital, London.
C R
CR
Chapple
E J
EJ
Milroy
D
D
Rickards
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications* / Q000473:pathology; D012307:Risk Factors; D015607:Stents; D013997:Time Factors; D014463:Ultrasonography; D014521:Urethra / Q000473:pathology / Q000601:surgery; D014524:Urethral Obstruction / Q000209:etiology / Q000628:therapy*; D014563:Urodynamics